Subtle Medical received FDA clearance for SubtleHD (PET), a next generation AI PET image enhancement product for PET/CT and PET/MR systems. The company states it supports all FDA approved radiotracers, enables up to 75 percent faster PET imaging on existing scanners, improves SUVmax quantitation accuracy, allows radiologist adjustable denoising levels, and incorporates anatomical CT data into reconstruction. It extends prior clearances covering SubtlePET and SubtleHD (MR).
Our readPET scanner capacity is a hard constraint for most imaging programs, and acquisition acceleration is one of the few levers that adds throughput without capital equipment. The material detail for buyers is radiotracer compatibility: support across all FDA approved radiotracers, rather than 18F-FDG alone, is what makes this usable in theranostics and advanced molecular imaging programs where the older generation was limited. Two caveats worth carrying into procurement: the acceleration figure is a vendor claim and should be validated against your own protocols and reader acceptance, and adjustable denoising means image appearance becomes a configurable parameter, which needs a documented standard rather than per radiologist preference drift.